Quanterix Corporation Finite-Lived Intangible Asset, Expected Amortization, Year One
Quanterix Corporation (QTRX) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $13.16 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-08-10
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $13.16M.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $13.19M.
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $13.26M.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $13.11M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2026-06-30 | $13.16M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $13.19M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $13.26M 10-K · filed 2026-03-02 |
| 2025-09-30 | $13.11M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $2.48M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $2.38M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $1.37M 10-K · filed 2025-03-17 |
| 2023-12-31 | $1.63M 10-K/A · filed 2024-12-26 |
| 2022-12-31 | $1.67M 10-K · filed 2023-03-06 |
| 2021-12-31 | $1.93M 10-K · filed 2022-03-01 |
| 2021-09-30 | $1.93M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $1.93M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $1.93M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $2.01M 10-K · filed 2021-03-05 |
| 2019-12-31 | $2.11M 10-K · filed 2020-03-13 |
| 2019-09-30 | $546.00K 10-Q · filed 2019-11-08 |
| 2019-06-30 | $287.00K 10-Q · filed 2019-08-06 |
| 2019-03-31 | $431.00K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $582.00K 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |